Study Watch vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Verily
VS
by Viz.ai

AI Verdict

Study Watch is designed for continuous physiological monitoring and data collection in clinical research, offering broad sensor data for various specialties. In contrast, Viz HCM is an AI-powered clinical decision support tool specifically for real-time detection of Hypertrophic Cardiomyopathy and coordinating subsequent care. Therefore, while both leverage AI in cardiology, Study Watch focuses on data acquisition for research, whereas Viz HCM targets specific disease diagnosis and care pathway optimization.

Choose Study Watch if…

Choose Verily Study Watch if your primary goal is to conduct in-depth clinical research requiring continuous, long-term physiological monitoring across multiple parameters. This device is ideal for studies needing extensive data collection on ECG, heart rate, and movement for later analysis and algorithm development in a cloud-based platform.

View Study Watch →

Choose Viz HCM if…

Choose Viz HCM if your institution needs an AI-powered solution for real-time detection of suspected Hypertrophic Cardiomyopathy directly from ECGs within a clinical workflow. This tool is best suited for accelerating diagnosis and streamlining the coordination of care for HCM patients by providing immediate alerts and directing them to appropriate specialists.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Study Watch Viz HCM
Deployment The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Viz HCM focuses on seamless integration into existing clinical workflows and provides real-time, mobile-based alerts for care teams, directly enhancing clinician usability for active patient management. Study Watch's usability is primarily for patients wearing the device passively and researchers analyzing data in a separate cloud platform, which is less about immediate clinical action.

Clinical Value

Viz HCM

Viz HCM offers direct and immediate clinical value by providing an FDA-cleared AI for real-time disease detection, significantly reducing diagnosis time for HCM and coordinating care. Study Watch primarily collects physiological data for research, which has indirect clinical value but does not offer the same immediate, actionable diagnostic and care coordination benefits.

Pricing & Value

Viz HCM

Viz HCM provides transparent pricing information, including a subscription model and specific CMS reimbursement codes with payment rates, allowing healthcare systems to clearly assess the financial value. Study Watch's pricing is not publicly available, making it impossible to evaluate its cost-effectiveness or value proposition.

Enterprise Readiness

Viz HCM

Viz HCM is explicitly designed for integration into existing hospital IT systems like EHR and PACS, and aims to streamline clinical workflows for care coordination, demonstrating strong enterprise readiness for clinical operations. While Study Watch is FDA cleared and compliant, its focus on clinical research implies a different type of enterprise integration, less directly tied to day-to-day patient care delivery within a hospital system.

Innovation

Viz HCM

Viz HCM demonstrates a higher degree of innovation in applying AI for real-time, actionable disease detection and automated care coordination, directly transforming clinical workflows and patient pathways. Study Watch's innovation lies more in advanced wearable sensor technology for data collection and analysis in research settings.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability, quality, or scope of support and documentation for either Verily Study Watch or Viz HCM. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Study Watch Viz HCM
Name Study Watch Viz HCM
Company Verily Life Sciences Viz.ai
Description Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Key Features Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications to multidisciplinary care teams, Automated direction of patients to appropriate care specialists, Reduces time to diagnosis and treatment for HCM, Streamlines cardiac care coordination and clinical workflows, Seamless integration with existing clinical workflows, EHR, and PACS systems, Clinically validated with extensive real-world evidence and publications

Videos

Demos, reviews, and walkthroughs featuring Study Watch and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Verily Study Watch is a prescription-only wearable device designed for non-invasive, continuous physiological monitoring primarily in clinical research, collecting data like ECG, heart rate, and movement. In contrast, Viz HCM is an FDA-cleared AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, aiming to reduce diagnosis time in clinical practice.
Verily Study Watch uploads collected data to Verily's cloud platform for processing and analysis. Viz HCM is a cloud-based platform that integrates into hospital IT systems, including EHR and PACS, to streamline cardiac care coordination and clinical workflows.
Verily Study Watch focuses on continuous physiological monitoring, collecting multiple physiological sensors such as ECG, heart rate, electrodermal activity, and inertial movements, and has been used in studies for conditions like Parkinson's and heart failure. Viz HCM specifically utilizes AI-powered ECG analysis for the real-time detection of Hypertrophic Cardiomyopathy (HCM).
Verily states its products are built to meet healthcare data protection standards and are designed to meet all applicable HIPAA requirements, and it conducts independent audits. However, an ongoing lawsuit alleges HIPAA violations and breaches of BAAs, which Verily denies. Viz.ai states that Viz HCM is HIPAA compliant and has a Business Associate Agreement (BAA).
Verily Study Watch acquires data through a prescription-only, sensor-based wearable device that provides non-invasive, continuous physiological monitoring. Viz HCM employs an AI algorithm to analyze real-time 12-lead ECG data to detect suspected HCM.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.